Giovanni Di Perri
Quick facts
Marketed products
- emtricitabine, darunavir/cobicistat, maraviroc · Infectious Disease / Virology
This is a three-drug combination that inhibits HIV replication through multiple mechanisms: emtricitabine and darunavir block reverse transcriptase and protease respectively, cobicistat enhances darunavir levels, and maraviroc blocks the CCR5 co-receptor. - raltegravir and atazanavir and ritonavir · Infectious Disease / Virology
This is a three-drug antiretroviral combination that inhibits HIV replication through complementary mechanisms: raltegravir blocks HIV integrase, while atazanavir and ritonavir inhibit HIV protease.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: